Company intelligence / Profile preview

OncoBLAZE

Charleston, South Carolina, United Statesoncoblaze.com ↗

Ownership: Private
Employees: ~10
Development stage: Preclinical

Overview

OncoBLAZE has developed a novel platform that combines thermo-sensitive liposomal nanoparticles with a precision laser heating device to deliver chemotherapy directly and precisely to residual cancer cells after surgery. This approach aims to prevent tumor recurrence by eradicating microscopic disease left behind post-resection. The company has secured two Phase I STTR grants from the NIH and NSF in its first year, supporting preclinical studies in rodent models. No human clinical data yet; preclinical validation ongoing.

Therapeutic areas: Oncology
Modalities: Thermo-sensitive liposomal nanoparticles (drug delivery)Chemotherapy agents (delivered via platform)Precision laser/heat-triggered drug release
Industry: Biotech

Partnerships

Academic partnership with Medical University of South Carolina (MUSC) for research collaboration/subcontracting on grant projects.

Beyond the preview

Go deeper on OncoBLAZE.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on OncoBLAZE.

Explore the full profile